Mirco Cosottini

Prof. Mirco Cosottini

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2015 in Epilepsia
Verified
Journal Article
Open access
PDF file
RGRenzo Guerrini
Renzo Guerrini
MDMichael Duchowny
Michael Duchowny
PJPrasanna Jayakar
Prasanna Jayakar
PKPavel Krsek
Pavel Krsek
PKPhilippe Kahane
Philippe Kahane
IBIngmar Blumcke
Ingmar Blumcke
Summary: Our inability to adequately treat many patients with refractory epilepsy caused by focal cortical dysplasia (FCD), surgical inaccessibility and failures are significant clinical drawbacks. The targeting of physiologic features of epileptogenesis in FCD and colocalizing functionality has enhanced completeness of surgical resection, the main determinant of outcome. Electroencephalography (EEG)–functional magnetic resonance imaging (fMRI) and magnetoencephalography are helpful in guiding electrode implantation and surgical treatment, and high‐frequency oscillations help defining the extent of the epileptogenic dysplasia. Ultra high‐field MRI has a role in understanding the laminar organization of the cortex, and fluorodeoxyglucose–positron emission tomography (FDG‐PET) is highly sensitive for detecting FCD in MRI‐negative cases. Multimodal imaging is clinically valuable, either by improving the rate of postoperative seizure freedom or by reducing postoperative deficits. However, there is no level 1 evidence that it improves outcomes. Proof for a specific effect of antiepileptic drugs (AEDs) in FCD is lacking. Pathogenic mutations recently described in mammalian target of rapamycin (mTOR) genes in FCD have yielded important insights into novel treatment options with mTOR inhibitors, which might represent an example of personalized treatment of epilepsy based on the known mechanisms of disease. The ketogenic diet (KD) has been demonstrated to be particularly effective in children with epilepsy caused by structural abnormalities, especially FCD. It attenuates epigenetic chromatin modifications, a master regulator for gene expression and functional adaptation of the cell, thereby modifying disease progression. This could imply lasting benefit of dietary manipulation. Neurostimulation techniques have produced variable clinical outcomes in FCD. In widespread dysplasias, vagus nerve stimulation (VNS) has achieved responder rates >50%; however, the efficacy of noninvasive cranial nerve stimulation modalities such as transcutaneous VNS (tVNS) and noninvasive (nVNS) requires further study. Although review of current strategies underscores the serious shortcomings of treatment‐resistant cases, initial evidence from novel approaches suggests that future success is possible.

18 January 2016 in Epilepsia
Verified
Journal Article
Closed access
PDF file
ACAlessio De Ciantis
Alessio De Ciantis
CBCarmen Barba
Carmen Barba
LTLaura Tassi
Laura Tassi
MCMirco Cosottini
Mirco Cosottini
MTMichela Tosetti
Michela Tosetti
RGRenzo Guerrini
Renzo Guerrini

1 October 2005 in Radiology
Verified
Journal Article
Closed access
MCMirco Cosottini
Mirco Cosottini
MGMarco Giannelli
Marco Giannelli
GSGabriele Siciliano
Gabriele Siciliano
GLGuido Lazzarotti
Guido Lazzarotti
MMMaria Chiara Michelassi
Maria Chiara Michelassi
LMLuigi Murri
Luigi Murri
PURPOSE: To prospectively evaluate several diffusion-tensor magnetic resonance (MR) imaging indexes (mean diffusivity [MD], fractional anisotropy [FA], and eigenvalues) of corticospinal tract impairment in patients with progressive muscular atrophy (PMA) and patients with amyotrophic lateral sclerosis (ALS). MATERIALS AND METHODS: This study had institutional review board approval, and written informed consent was obtained from all subjects. Eight male patients with PMA (mean age, 63 years ± 13 [standard deviation]), eighteen patients with ALS (14 men and four women; mean age, 64 years ± 7), and twelve control subjects (four men and eight women; mean age, 65 years ± 6) underwent diffusion-tensor MR imaging at which 25 spin-echo echo-planar imaging diffusion-weighted images (b = 1000 sec/mm2) were acquired along noncollinear directions. MD and FA were measured along the corticospinal tracts in each patient and subject. Changes in diffusion along and orthogonal to fiber bundles in patients were evaluated by...

1 June 2014 in Radiology
Verified
Journal Article
Open access
MCMirco Cosottini
Mirco Cosottini
DFDaniela Frosini
Daniela Frosini
IPIlaria Pesaresi
Ilaria Pesaresi
MCMauro Costagli
Mauro Costagli
LBLaura Biagi
Laura Biagi
MTMichela Tosetti
Michela Tosetti
This study demonstrates the capability of 7-T MR imaging to depict the borders of substantia nigra (SN) and its inner organization and reveals simple radiologic signs that show the loss of the three-layered organization and of the lateral spot of SN in patients with Parkinson disease. PurposeTo evaluate the anatomy of the substantia nigra (SN) in healthy subjects by performing 7-T magnetic resonance (MR) imaging of the SN, and to prospectively define the accuracy of 7-T MR imaging in distinguishing Parkinson disease (PD) patients from healthy subjects on an individual basis.Materials and MethodsThe 7-T MR imaging protocol was approved by the Italian Ministry of Health and by the local competent ethics committee. SN anatomy was described ex vivo on a gross brain specimen by using highly resolved proton-density (spin-echo proton density) and gradient-recalled-echo (GRE) images, and in vivo in eight healthy subjects (mean age, 40.1 years) by using GRE three-dimensional multiecho susceptibility-weighted images. After training on appearance of SN in eight healthy subjects, the SN anatomy was evaluated twice by two blinded observers in 13 healthy subjects (mean age, 54.7 years) and in 17 PD patients (mean age, 56.9 years). Deviations from normal SN appearance were described and indicated as ...

21 June 2007 in Acta Neurologica Scandinavica
Verified
Journal Article
Closed access
PDF file
MCMirco Cosottini
Mirco Cosottini
RCRoberto Ceravolo
Roberto Ceravolo
Lorenzo FaggioniLorenzo Faggioni
Lorenzo Faggioni
GLG. Lazzarotti
G. Lazzarotti
MMM. C. Michelassi
M. C. Michelassi
CBC. Bartolozzi
C. Bartolozzi
Objectives – To assess midbrain atrophy through morphometric (linear, surface and volumetric) measurements in patients with clinically diagnosed progressive supranuclear palsy (PSP) and to establish the most accurate measure to be implemented in routine magnetic resonance (MR) protocol in distinguishing PSP from healthy subjects and MSA‐p (multiple system atrophy, parkinsonian form) patients. Materials and methods – We studied 15 patients with the diagnosis of probable PSP, seven patients with the diagnosis of probable MSA‐p and 14 age‐matched healthy volunteers. MR protocol includes a sagittal SE T1‐weighted sequence for cross‐sectional area and linear brainstem measurements and a 3D‐FSPGR sequence for brainstem volume measurements. Results – A highly significant difference in the antero‐posterior midbrain diameter, area and volume in PSP compared with control subjects was found. Only a measurement of the midbrain area and pons area enabled one to distinguish between PSP and MSA‐p. Receiver operating characteristic analysis revealed that the midbrain area has the highest diagnostic accuracy in distinguishing between PSP and other conditions, with a sensitivity of 100% and specificity of 90.5%. The addition of the midbrain area/pons area ratio (Ams/Apn ratio) measurement improves the specificity in distinguishing between PSP and MSA. Conclusions – Morphological indexes indicate midbrain atrophy in PSP patients The combination of the Ams and Ams/Apn ratio measurements allows to discriminate between PSP and other conditions.

1 September 2015 in Magnetic Resonance Imaging
Verified
Journal Article
Closed access
JGJoseph Goveas
Joseph Goveas
LOLaurence O’dWyer
Laurence O’dWyer
MMMario Mascalchi
Mario Mascalchi
MCMirco Cosottini
Mirco Cosottini
SDStefano Diciotti
Stefano Diciotti
MGMarco Giannelli
Marco Giannelli